Business report

High Flow Nasal Cannulas Market: A Global Strategic Business Report

Rising incidence of respiratory diseases, technological advancements in high-flow nasal cannulas, and growing demand for home care are some of the major factors driving the growth of the global high-flow nasal cannulas market.

NEWARK, Del., April 26, 2022 /PRNewswire/ — The World High Flow Nasal Cannulas Market should reach US$7.37 billion in 2022, at a CAGR of 11.6% to reach $17.7 billion by 2030. Sales of high-flow nasal cannulas currently account for 35.3% of the global respiratory care device market. Rising cases of respiratory diseases, along with technological improvements in high-flow nasal cannula systems, are driving the expansion of the market.

IMF_Logo

There has been a noticeable increase in respiratory disorders in recent years. According to the 2017 GBD (Global Burden of Diseases) study, pneumoconiosis and COPD cases increased by 81.1% and 49.8% respectively from 1990 to 2017, and the number is expected to grow exponentially over the period. forecast.

Additionally, research indicates that high-flow nasal cannula oxygenation is proving to be an effective mode of treatment for current Covid-19 caused by acute respiratory failure by noninvasive positive pressure ventilation (NIPPV). As such, the global high-flow nasal cannula market is expected to see both short-term and long-term traction.

Get a sample copy of the report: https://www.futuremarketinsights.com/reports/sample/rep-gb-11269

Key Takeaways from the High Flow Nasal Cannulas Market Research

  • Home Care Facilities Hold Largest Market Share in 2020 Due to Covid-19 Outbreak

  • Sales through e-commerce channels spike, with end users showing strong preference for contactless delivery

  • Single-use high-flow nasal cannulas to replace reusable nasal cannulas over the forecast period due to growing awareness of cross-contamination

High Flow Nasal Cannulas Market: Competitive Landscape

Players in the High Flow Nasal Cannulas market are in expansion mode regarding their portfolio to gain a competitive advantage over each other. They also get into the inorganic growth mode to spare no effort regarding their market presence.

For example –

– Hamilton Medical AG, in February 2019, has trademarked “Nuflow Single-Use Nasal Cannulas” to facilitate high-flow oxygen therapy for neonates. These cannulas could be found in 4 different sizes including a pair of fixing patches and an adapter
– Teijin is privileged to launch the first oxygen concentrator for Japan; i.e. “Mildsanso”. When it comes to cardiovascular disease, Teijin’s Continuous Positive Airway Pressure (CPAP) devices hold more than 40% of the global CPAP market. Japan.
– Salter Laboratories have 15 LPM cannulas when there is more oxygen demand. ALOFT cannulas are designed for extra comfort, especially for the geriatric population
– OmniOx from MEK-ICS Co., Ltd. Enables the delivery of optimal humidification and has an adjustable FiO2 with 21~100%

Smiths Medical has its Pediatric Split CO2/O2 Nasal Cannula, Adult Oral/Nasal CO2, Pediatric O2 Nasal Cannula under its CO2 Sampling Line

In November 2017Teijin Pharma and SRETT have agreed on an exclusive distribution agreement everywhere Japan for “TeleOx”. This device monitors respiratory functions in oxygen therapy. It is designed by SRETT

Ask us your questions about this report: https://www.futuremarketinsights.com/ask-question/rep-gb-11269

Profiled Key Companies

Key segments of the High Flow Nasal Cannulas industry survey

High Flow Nasal Cannulas Market By Component:

High Flow Nasal Cannulas Market by Medical Application:

High Flow Nasal Cannulas Market by End User:

  • Hospitals

  • Specialized clinics

  • Long-term care centers

  • Ambulatory care centers

  • Home care settings

Contact Sales for further assistance with purchasing this [email protected] https://www.futuremarketinsights.com/checkout/11269

Main reports related to Health care Market overview

Acute migraine treatment market– Global Acute Migraine Treatment market size is expected to be valued at US$8.6 billion in 2032 and show a CAGR of 4.9% over the forecast period from 2022 to 2032.

Neurovascular Access Catheters Market– The global sales of Neurovascular Access Catheters are expected to grow at a stable CAGR of around 4.8% and 5% between 2022 and 2032, generating considerable revenue by the end of the forecast period.

About Future Market Insights (IMF)

Future Market Outlook (ESOMAR-certified research organization and member of Greater New York Chamber of Commerce) provides detailed information on the driving factors that increase the demand in the market. It reveals opportunities that will drive market growth in various segments on the basis of source, application, sales channel, and end-use over the next 10 years.

Contact:
Future Market Outlook Inc.
Christiana Corporate, 200 Continental Drive,
Office 401, Newark, Delaware – 19713, UNITED STATES
Such. : +1-845-579-5705
For sales inquiries: [email protected]
Website: https://www.futuremarketinsights.com
Report: https://www.futuremarketinsights.com/reports/high-flow-nasal-cannula-market
LinkedIn| Twitter| Blogs

Quote

Quote

Show original content:https://www.prnewswire.com/news-releases/high-flow-nasal-cannula-market-a-global-strategic-business-report–future-market-insights-301533312.html

SOURCE Future Market Outlook